Eric Bjerkholt
Director of Finance/CFO presso MIRUM PHARMACEUTICALS, INC.
Patrimonio netto: 635 637 $ in data 31/03/2024
Profilo
Mr. Eric H.
Bjerkholt is a Chief Financial Officer at Mirum Pharmaceuticals, Inc., an Independent Director at Surrozen, Inc., an Independent Director at CalciMedica, Inc. and an Independent Director at Cerus Corp.
He is on the Board of Directors at Surrozen, Inc., CalciMedica, Inc., Cerus Corp.
and Aimmune Therapeutics UK Ltd.
Mr. Bjerkholt was previously employed as a Chief Financial Officer by Chinook Therapeutics, Inc., an Independent Director by Graybug Vision, Inc., a Chief Financial Officer by Aimmune Therapeutics, Inc., an Independent Director by Ambrx, Inc., an Independent Director by StemCells, Inc., a CFO, Secretary & EVP-Corporate Development by Sunesis Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by IntraBiotics Pharmaceuticals, Inc., a President, Chief Executive & Financial Officer by LifeSpring Home Nutrition, a President, Chief Executive & Financial Officer by Kenady LLC, and a Vice President by J.P.
Morgan & Co., Inc. (Delaware).
He also served on the board at Corium International, Inc., Atara Biotherapeutics, Inc., Round Table Pizza, Inc. and Structure Therapeutics, Inc. He received his undergraduate degree from the University of Oslo and an MBA from Harvard Business School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 27/03/2024 | 14 000 ( 0.03% ) | 351 680 $ | 31/03/2024 | |
CERUS CORPORATION
0.08% | 13/12/2023 | 142 133 ( 0.08% ) | 268 631 $ | 31/03/2024 |
CALCIMEDICA, INC.
0.03% | 31/05/2023 | 3 684 ( 0.03% ) | 15 325 $ | 31/03/2024 |
Posizioni attive di Eric Bjerkholt
| Società | Posizione | Inizio |
|---|---|---|
| CERUS CORPORATION | Director/Board Member | 09/10/2018 |
| CALCIMEDICA, INC. | Director/Board Member | 20/03/2023 |
| SURROZEN, INC. | Director/Board Member | 05/04/2023 |
| MIRUM PHARMACEUTICALS, INC. | Director of Finance/CFO | 11/09/2023 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Stallergenes Greer Ltd., Aimmune Therapeutics UK Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Cheltenham, UK. Aimmune Therapeutics was founded in 2015. | Director/Board Member | 16/11/2018 |
Precedenti posizioni note di Eric Bjerkholt
| Società | Posizione | Fine |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director of Finance/CFO | 01/09/2023 |
| AIMMUNE THERAPEUTICS, INC. | Director of Finance/CFO | 01/10/2020 |
| CORIUM INTERNATIONAL INC | Director/Board Member | 27/11/2018 |
| VIRACTA THERAPEUTICS, INC. | Director of Finance/CFO | 27/04/2017 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formazione di Eric Bjerkholt
| University of Oslo | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 6 |
|---|---|
| CERUS CORPORATION | Health Technology |
| MIRUM PHARMACEUTICALS, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| SURROZEN, INC. | Health Technology |
| CALCIMEDICA, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 13 |
|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Round Table Pizza, Inc.
 Round Table Pizza, Inc. RestaurantsConsumer Services Round Table Pizza, Inc. owns and operates pizza franchise outlets. It offers picked produce, premium meats, and cheeses. The company was founded by Bill Larson in 1959 and is headquartered in Concord, CA. | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Corium International, Inc.
 Corium International, Inc. Pharmaceuticals: MajorHealth Technology Corium International, Inc. is a pharmaceutical company. It offers products such as corplex donepezil and memantine. The company was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA. | Health Technology |
LifeSpring Home Nutrition
 LifeSpring Home Nutrition RestaurantsConsumer Services LifeSpring Home Nutrition provides food items on delivery. The company was founded in 1997 and is headquartered in Irvine, CA. | Consumer Services |
Kenady LLC
 Kenady LLC Food DistributorsDistribution Services Kenady Corp. distributes frozen meals and snacks, and offers delivery services. It includes meals and snacks, direct-to-home and direct-to-office delivery through their uniformed drivers, and nutrition counseling and preparation of custom meal plans. The company was founded in 2003 and is headquartered in Irvine, CA. | Distribution Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
J.P. Morgan & Co., Inc. (Delaware)
 J.P. Morgan & Co., Inc. (Delaware) Financial ConglomeratesFinance Part of JPMorgan Chase & Co., J.P. Morgan & Co., Inc. is a financial services company based in New York. The American company provides financial services. | Finance |
Aimmune Therapeutics UK Ltd.
Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Stallergenes Greer Ltd., Aimmune Therapeutics UK Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Cheltenham, UK. Aimmune Therapeutics was founded in 2015. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Borsa valori
- Insiders
- Eric Bjerkholt
